FILGRASTIM-AAFI

FILGRASTIM-AAFI was reported 669 times

FILGRASTIM-AAFI is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FIRST TRIMESTER PREGNANCY 1 0.0400
1 BLOOD STEM CELL HARVEST 1 0.0270
2 WATER POLLUTION 1 0.0238
3 DOUBLE HIT LYMPHOMA 1 0.0200
4 PERITONEAL CARCINOMA METASTATIC 1 0.0159
5 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE 1 0.0149
6 DRAIN REMOVAL 1 0.0135
7 NEUROBLASTOMA 3 0.0078
8 COMPLEMENT FACTOR C4 DECREASED 1 0.0052
9 GROWTH ACCELERATED 1 0.0046
10 HEPATIC RUPTURE 1 0.0045
11 COMPLEMENT FACTOR C3 DECREASED 1 0.0041
12 PRIMARY AMYLOIDOSIS 1 0.0039
13 LYMPHOCYTE ADOPTIVE THERAPY 1 0.0036
14 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
15 POLYCHROMASIA 1 0.0033
16 WRONG STRENGTH 1 0.0030
17 ADRENAL GLAND CANCER 1 0.0026
18 STEM CELL TRANSPLANT 6 0.0024
19 VERTEBRAL OSTEOPHYTE 1 0.0023
20 BONE MARROW TRANSPLANT 4 0.0021
21 DRAINAGE 1 0.0020
22 METASTASES TO BONE MARROW 1 0.0020
23 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
24 GROIN INFECTION 1 0.0018
25 TUMOUR RUPTURE 1 0.0018
26 PROSTATECTOMY 1 0.0017
27 TRANSPLANT 4 0.0017
28 MONOCLONAL GAMMOPATHY 1 0.0016
29 CHORIORETINITIS 1 0.0016
30 RENAL SURGERY 1 0.0015
31 DERMATITIS DIAPER 1 0.0014
32 METAPNEUMOVIRUS INFECTION 1 0.0013
33 FEAR OF FALLING 1 0.0012
34 CANCER PAIN 3 0.0012
35 ENTEROVIRUS INFECTION 1 0.0012
36 ENTEROCOLITIS INFECTIOUS 1 0.0011
37 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
38 RED BLOOD CELL ABNORMALITY 1 0.0010
39 DEVICE SAFETY FEATURE ISSUE 1 0.0010
40 BLADDER CANCER RECURRENT 1 0.0010
41 EMERGENCY CARE 3 0.0010
42 HYPOPERFUSION 1 0.0010
43 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
44 CARDIAC AMYLOIDOSIS 1 0.0009
45 SUSPECTED OFF LABEL USE 4 0.0009
46 T-CELL LYMPHOMA 1 0.0009
47 SPLENECTOMY 1 0.0009
48 DEVICE DISPENSING ERROR 1 0.0008
49 LUNG TRANSPLANT 3 0.0008
50 BLOOD UREA DECREASED 1 0.0008
51 CHEMOTHERAPY 3 0.0008
52 ABDOMINAL INFECTION 2 0.0008
53 EXTRADURAL HAEMATOMA 1 0.0008
54 DEVICE DEFECTIVE 13 0.0007
55 ANION GAP INCREASED 1 0.0007
56 INTENSIVE CARE 1 0.0007
57 DEVICE OPERATIONAL ISSUE 3 0.0007
58 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
59 GALLBLADDER CANCER 1 0.0007
60 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
61 INFUSION SITE INDURATION 1 0.0007
62 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
63 BONE MARROW DISORDER 2 0.0007
64 INHIBITORY DRUG INTERACTION 1 0.0006
65 CYSTITIS INTERSTITIAL 1 0.0006
66 NEEDLE ISSUE 18 0.0006
67 LEUKAEMIA RECURRENT 1 0.0006
68 DEVICE MECHANICAL ISSUE 8 0.0006
69 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
70 PNEUMONIA KLEBSIELLA 1 0.0005
71 BLOOD IRON INCREASED 1 0.0005
72 IMPATIENCE 1 0.0005
73 PYELONEPHRITIS ACUTE 1 0.0005
74 GENE MUTATION 1 0.0005
75 HICCUPS 4 0.0005
76 NEUTROPENIC COLITIS 1 0.0005
77 FULL BLOOD COUNT ABNORMAL 5 0.0005
78 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
79 METASTATIC NEOPLASM 2 0.0005
80 BONE CANCER 2 0.0005
81 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
82 CEREBELLAR SYNDROME 1 0.0005
83 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
84 REACTION TO EXCIPIENT 1 0.0004
85 CONTRAST MEDIA REACTION 1 0.0004
86 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
87 DEVICE LEAKAGE 18 0.0004
88 HAEMATOLOGICAL INFECTION 1 0.0004
89 HYPERVOLAEMIA 2 0.0004
90 SYSTEMIC CANDIDA 1 0.0004
91 PLATELET DISORDER 1 0.0004
92 AMMONIA INCREASED 2 0.0004
93 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
94 WHITE BLOOD CELL DISORDER 1 0.0004
95 ORAL FUNGAL INFECTION 1 0.0004
96 MACULE 1 0.0004
97 SKIN HYPERTROPHY 1 0.0004
98 NEUTROPHIL COUNT ABNORMAL 1 0.0004
99 BREAST CANCER STAGE IV 1 0.0004
100 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
101 TUMOUR HAEMORRHAGE 1 0.0004
102 LUNG CANCER METASTATIC 1 0.0003
103 LUNG ADENOCARCINOMA 1 0.0003
104 CENTRAL VENOUS CATHETERISATION 1 0.0003
105 BLOOD BLISTER 1 0.0003
106 DEVICE DEPLOYMENT ISSUE 4 0.0003
107 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
108 INFUSION SITE HAEMORRHAGE 1 0.0003
109 SKIN INJURY 1 0.0003
110 POOR QUALITY DEVICE USED 3 0.0003
111 FULL BLOOD COUNT DECREASED 6 0.0003
112 B-CELL LYMPHOMA 1 0.0003
113 PRODUCT PRESCRIBING ERROR 7 0.0003
114 WOUND COMPLICATION 1 0.0003
115 BONE PAIN 17 0.0003
116 BLOOD CREATININE ABNORMAL 1 0.0003
117 SYRINGE ISSUE 5 0.0003
118 BLOOD TEST ABNORMAL 4 0.0003
119 BONE LESION 1 0.0003
120 RENAL TRANSPLANT 1 0.0003
121 LIVER TRANSPLANT 1 0.0003
122 HYDRONEPHROSIS 2 0.0003
123 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
124 APHTHOUS ULCER 2 0.0003
125 RHINOVIRUS INFECTION 1 0.0003
126 CARDIOPULMONARY FAILURE 1 0.0003
127 ORAL INFECTION 1 0.0003
128 OESOPHAGEAL CANDIDIASIS 1 0.0003
129 RECURRENT CANCER 1 0.0002
130 GASTROINTESTINAL PERFORATION 1 0.0002
131 TONGUE DISCOMFORT 1 0.0002
132 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
133 ABDOMINAL ABSCESS 1 0.0002
134 WHEELCHAIR USER 1 0.0002
135 NEUTROPHIL COUNT DECREASED 9 0.0002
136 URINE ABNORMALITY 1 0.0002
137 HAEMOGLOBIN INCREASED 1 0.0002
138 LEUKAEMIA 2 0.0002
139 SKIN ABRASION 1 0.0002
140 KIDNEY TRANSPLANT REJECTION 1 0.0002
141 HUMERUS FRACTURE 1 0.0002
142 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
143 THERAPY CHANGE 2 0.0002
144 HOSPICE CARE 2 0.0002
145 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
146 LYMPHOMA 3 0.0002
147 VARICOSE VEIN 1 0.0002
148 FAILURE TO THRIVE 1 0.0002
149 ACUTE MYELOID LEUKAEMIA 3 0.0002
150 TRANSFUSION 2 0.0002
151 BLOOD LACTIC ACID INCREASED 1 0.0002
152 EAR INFECTION 5 0.0002
153 COMPRESSION FRACTURE 1 0.0002
154 OVERWEIGHT 1 0.0002
155 HYPOACUSIS 8 0.0002
156 GINGIVITIS 1 0.0002
157 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
158 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
159 NONSPECIFIC REACTION 1 0.0002
160 NEOPLASM MALIGNANT 12 0.0002
161 HYPERVENTILATION 1 0.0002
162 DEVICE BREAKAGE 7 0.0002
163 PRODUCT LABEL CONFUSION 1 0.0002
164 SPLENOMEGALY 2 0.0002
165 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
166 BACTERAEMIA 2 0.0002
167 GASTROENTERITIS VIRAL 3 0.0002
168 PLATELET COUNT ABNORMAL 1 0.0002
169 INFUSION SITE SWELLING 1 0.0002
170 HOSPITALISATION 24 0.0002
171 HAEMOGLOBIN ABNORMAL 1 0.0002
172 NODULE 2 0.0002
173 PRODUCT PREPARATION ISSUE 1 0.0002
174 UPPER LIMB FRACTURE 3 0.0002
175 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
176 DRUG DOSE OMISSION BY DEVICE 11 0.0001
177 PRODUCT SUPPLY ISSUE 1 0.0001
178 METASTASIS 1 0.0001
179 PARALYSIS 2 0.0001
180 PRODUCT DISPENSING ERROR 3 0.0001
181 MOUTH HAEMORRHAGE 1 0.0001
182 COLON CANCER 2 0.0001
183 PLASMA CELL MYELOMA 5 0.0001
184 BRAIN FOG 2 0.0001
185 ILLNESS 13 0.0001
186 THERAPY INTERRUPTED 9 0.0001
187 FRUSTRATION TOLERANCE DECREASED 1 0.0001
188 FEBRILE NEUTROPENIA 8 0.0001
189 VIRAL INFECTION 4 0.0001
190 BLOOD UREA INCREASED 2 0.0001
191 INFUSION SITE ERYTHEMA 1 0.0001
192 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
193 SKIN HYPERPIGMENTATION 1 0.0001
194 BLOOD MAGNESIUM DECREASED 1 0.0001
195 MYOPATHY 1 0.0001
196 EXPOSURE VIA SKIN CONTACT 3 0.0001
197 SKIN SWELLING 1 0.0001
198 NEUROTOXICITY 2 0.0001
199 SPINAL OSTEOARTHRITIS 1 0.0001
200 IMMUNOSUPPRESSION 1 0.0001
201 RESPIRATORY RATE INCREASED 1 0.0001
202 BONE DISORDER 2 0.0001
203 DEATH 94 0.0001
204 OVARIAN CANCER 1 0.0001
205 PRODUCT DISTRIBUTION ISSUE 1 0.0001
206 NEPHROPATHY 1 0.0001
207 PRODUCT PACKAGING ISSUE 1 0.0001
208 POST PROCEDURAL COMPLICATION 2 0.0001
209 INFECTION 15 0.0001
210 ERUCTATION 2 0.0001
211 BONE MARROW FAILURE 2 0.0001
212 MOTOR DYSFUNCTION 1 0.0001
213 NEUTROPHIL COUNT INCREASED 1 0.0001
214 HYPERBILIRUBINAEMIA 1 0.0001
215 OFF LABEL USE 84 0.0001
216 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
217 SCRATCH 1 0.0001
218 JOINT DISLOCATION 1 0.0001
219 BODY HEIGHT DECREASED 1 0.0001
220 BREAST CANCER METASTATIC 1 0.0001
221 SKIN LACERATION 1 0.0001
222 GASTROINTESTINAL PAIN 1 0.0001
223 MALNUTRITION 1 0.0001
224 DEVICE ISSUE 8 0.0001
225 FISTULA 1 0.0001
226 CHOLECYSTECTOMY 1 0.0001
227 NEOPLASM 1 0.0001
228 NEOPLASM PROGRESSION 3 0.0001
229 SPINAL PAIN 1 0.0001
230 POLYNEUROPATHY 1 0.0001
231 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
232 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
233 BRAIN OEDEMA 1 0.0001
234 MUSCLE ATROPHY 1 0.0001
235 THERAPY CESSATION 4 0.0001
236 INFUSION SITE PAIN 1 0.0001
237 BLOOD CREATININE INCREASED 5 0.0001
238 DISEASE PROGRESSION 9 0.0001
239 IMMUNE SYSTEM DISORDER 1 0.0001
240 ADVERSE REACTION 1 0.0001
241 NEUROPATHY PERIPHERAL 7 0.0001
242 NEUTROPENIA 10 0.0001
243 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
244 RESPIRATORY DISTRESS 2 0.0001
245 PYREXIA 25 0.0001
246 HYPOMAGNESAEMIA 1 0.0001
247 APHONIA 1 0.0001
248 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
249 SUBDURAL HAEMATOMA 1 0.0001
250 MYELODYSPLASTIC SYNDROME 1 0.0001
251 SEPTIC SHOCK 3 0.0001
252 HYPOKINESIA 1 0.0001
253 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
254 LABORATORY TEST ABNORMAL 2 0.0001
255 IMMUNODEFICIENCY 1 0.0001
256 BLOOD POTASSIUM DECREASED 2 0.0001
257 BLOOD COUNT ABNORMAL 1 0.0001
258 STOMATITIS 4 0.0001
259 PLATELET COUNT DECREASED 7 0.0001
260 PRODUCT USE COMPLAINT 1 0.0001
261 PNEUMOTHORAX 1 0.0001
262 MUSCLE TIGHTNESS 1 0.0001
263 CYTOMEGALOVIRUS INFECTION 1 0.0001
264 FLUID RETENTION 3 0.0001
265 PRODUCT DOSE OMISSION ISSUE 17 0.0001
266 DEVICE USE ERROR 2 0.0001
267 SPEECH DISORDER 3 0.0001
268 DEVICE MALFUNCTION 4 0.0001
269 HYPOXIA 2 0.0001
270 MYELOSUPPRESSION 2 0.0001
271 LEUKOCYTOSIS 1 0.0001
272 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
273 AGRANULOCYTOSIS 1 0.0001
274 PANCYTOPENIA 3 0.0001
275 BACTERIAL INFECTION 1 0.0001
276 EPISTAXIS 4 0.0001
277 SURGERY 3 0.0001
278 CYTOKINE RELEASE SYNDROME 1 0.0000
279 PLEURAL EFFUSION 3 0.0000
280 TASTE DISORDER 1 0.0000
281 BODY TEMPERATURE INCREASED 1 0.0000
282 RIB FRACTURE 1 0.0000
283 MOUTH ULCERATION 1 0.0000
284 EATING DISORDER 1 0.0000
285 JOINT INJURY 1 0.0000
286 LIVER FUNCTION TEST INCREASED 1 0.0000
287 POOR QUALITY SLEEP 1 0.0000
288 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
289 PRODUCT DOSE OMISSION 3 0.0000
290 PRODUCT PRESCRIBING ISSUE 1 0.0000
291 DEVICE DIFFICULT TO USE 3 0.0000
292 TOOTH DISORDER 1 0.0000
293 HEPATOTOXICITY 1 0.0000
294 ORAL PAIN 1 0.0000
295 THERAPY NON-RESPONDER 2 0.0000
296 PRODUCT AVAILABILITY ISSUE 1 0.0000
297 MUSCLE SPASMS 8 0.0000
298 MALAISE 19 0.0000
299 PERICARDIAL EFFUSION 1 0.0000
300 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
301 COGNITIVE DISORDER 2 0.0000
302 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
303 CHILLS 5 0.0000
304 SLEEP DISORDER 3 0.0000
305 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
306 BLOOD PRESSURE FLUCTUATION 1 0.0000
307 LUNG DISORDER 2 0.0000
308 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
309 AGEUSIA 1 0.0000
310 HYPOAESTHESIA 6 0.0000
311 PNEUMONIA ASPIRATION 1 0.0000
312 LEUKOPENIA 2 0.0000
313 PRODUCT COMPLAINT 1 0.0000
314 JOINT STIFFNESS 1 0.0000
315 NASOPHARYNGITIS 7 0.0000
316 BREAST CANCER FEMALE 1 0.0000
317 PRODUCT USE ISSUE 7 0.0000
318 ASTHENIA 14 0.0000
319 FREQUENT BOWEL MOVEMENTS 1 0.0000
320 RASH PRURITIC 2 0.0000
321 PNEUMONITIS 1 0.0000
322 TREATMENT NONCOMPLIANCE 2 0.0000
323 MEMORY IMPAIRMENT 5 0.0000
324 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
325 PROCEDURAL PAIN 1 0.0000
326 MENTAL STATUS CHANGES 1 0.0000
327 FEELING COLD 1 0.0000
328 SEPSIS 4 0.0000
329 OXYGEN SATURATION DECREASED 2 0.0000
330 INTENTIONAL DOSE OMISSION 1 0.0000
331 RED BLOOD CELL COUNT DECREASED 1 0.0000
332 HYPERSOMNIA 1 0.0000
333 PANCREATIC CARCINOMA 1 0.0000
334 BACK PAIN 8 0.0000
335 COVID-19 6 0.0000
336 PAIN 21 0.0000
337 DIARRHOEA 22 0.0000
338 TACHYCARDIA 3 0.0000
339 RENAL INJURY 1 0.0000
340 RESPIRATORY DISORDER 1 0.0000
341 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
342 HEPATIC FAILURE 1 0.0000
343 FEMUR FRACTURE 1 0.0000
344 BREAST CANCER 3 0.0000
345 VOMITING 15 0.0000
346 PULMONARY EMBOLISM 3 0.0000
347 MOVEMENT DISORDER 1 0.0000
348 PNEUMONIA 10 0.0000
349 DEEP VEIN THROMBOSIS 2 0.0000
350 AMNESIA 2 0.0000
351 SWELLING FACE 2 0.0000
352 CHOLELITHIASIS 1 0.0000
353 INFUSION RELATED REACTION 2 0.0000
354 BLOOD PRESSURE DECREASED 2 0.0000
355 ABDOMINAL PAIN 7 0.0000
356 DYSPNOEA 17 0.0000
357 LIP SWELLING 1 0.0000
358 DEHYDRATION 4 0.0000
359 URINARY RETENTION 1 0.0000
360 GAIT INABILITY 1 0.0000
361 TYPE 2 DIABETES MELLITUS 1 0.0000
362 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
363 ANGER 1 0.0000
364 FATIGUE 23 0.0000
365 CEREBROVASCULAR ACCIDENT 5 0.0000
366 CHEST DISCOMFORT 3 0.0000
367 HAEMOGLOBIN DECREASED 3 0.0000
368 FEELING ABNORMAL 7 0.0000
369 GASTRIC DISORDER 1 0.0000
370 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
371 LYMPHADENOPATHY 1 0.0000
372 CEREBRAL HAEMORRHAGE 1 0.0000
373 CRYING 1 0.0000
374 EYE SWELLING 1 0.0000
375 HOT FLUSH 2 0.0000
376 ARTHRALGIA 11 0.0000
377 COLITIS 1 0.0000
378 DIABETES MELLITUS 2 0.0000
379 PALPITATIONS 3 0.0000
380 INJECTION SITE HAEMORRHAGE 2 0.0000
381 ERYTHEMA 5 0.0000
382 ABDOMINAL PAIN UPPER 5 0.0000
383 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
384 SKIN EXFOLIATION 2 0.0000
385 MYALGIA 4 0.0000
386 CONSTIPATION 5 0.0000
387 PRODUCT STORAGE ERROR 2 0.0000
388 MUSCULOSKELETAL STIFFNESS 2 0.0000
389 LIVER DISORDER 1 0.0000
390 INSOMNIA 6 0.0000
391 PULMONARY OEDEMA 1 0.0000
392 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
393 GASTROINTESTINAL DISORDER 2 0.0000
394 THROAT IRRITATION 1 0.0000
395 SKIN DISCOLOURATION 1 0.0000
396 CHEST PAIN 4 0.0000
397 DECREASED APPETITE 5 0.0000
398 RENAL DISORDER 1 0.0000
399 COUGH 6 0.0000
400 CARDIAC DISORDER 2 0.0000
401 DYSPHAGIA 2 0.0000
402 DISEASE RECURRENCE 1 0.0000
403 ANAEMIA 4 0.0000
404 RASH ERYTHEMATOUS 1 0.0000
405 GAIT DISTURBANCE 4 0.0000
406 PRURITUS 8 0.0000
407 RASH 9 0.0000
408 ATRIAL FIBRILLATION 2 0.0000
409 ALOPECIA 4 0.0000
410 SYNCOPE 2 0.0000
411 INJECTION SITE PAIN 6 0.0000
412 ABDOMINAL DISTENSION 2 0.0000
413 NERVOUSNESS 1 0.0000
414 ECZEMA 1 0.0000
415 PARAESTHESIA 3 0.0000
416 NAUSEA 15 0.0000
417 PANCREATITIS 1 0.0000
418 DEPRESSED MOOD 1 0.0000
419 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
420 CONFUSIONAL STATE 3 0.0000
421 ANAPHYLACTIC REACTION 1 0.0000
422 ARTHROPATHY 1 0.0000
423 INFLUENZA 2 0.0000
424 WEIGHT DECREASED 5 0.0000
425 THROMBOCYTOPENIA 2 0.0000
426 BLISTER 1 0.0000
427 FLATULENCE 1 0.0000
428 URINARY TRACT INFECTION 3 0.0000
429 HERPES ZOSTER 1 0.0000
430 EYE IRRITATION 1 0.0000
431 PRODUCT SUBSTITUTION ISSUE 1 0.0000
432 DYSPHONIA 1 0.0000
433 NASAL CONGESTION 1 0.0000
434 WHEEZING 1 0.0000
435 NO ADVERSE EVENT 3 0.0000
436 CONDITION AGGRAVATED 5 0.0000
437 DISCOMFORT 1 0.0000
438 FEELING HOT 1 0.0000
439 HYPERSENSITIVITY 3 0.0000
440 HEADACHE 10 0.0000
441 DRY SKIN 2 0.0000
442 BURNING SENSATION 1 0.0000
443 HYPERTENSION 3 0.0000
444 MOBILITY DECREASED 1 0.0000
445 PAIN IN EXTREMITY 4 0.0000
446 BRONCHITIS 1 0.0000
447 DYSGEUSIA 1 0.0000
448 UNEVALUABLE EVENT 1 0.0000
449 INCORRECT DOSE ADMINISTERED 3 0.0000
450 BLOOD PRESSURE INCREASED 2 0.0000
451 ACUTE KIDNEY INJURY 2 0.0000
452 INJECTION SITE SWELLING 1 0.0000
453 PERIPHERAL SWELLING 2 0.0000
454 CARDIAC FAILURE 1 0.0000
455 PROSTATE CANCER 1 0.0000
456 THROMBOSIS 1 0.0000
457 DRY MOUTH 1 0.0000
458 ABDOMINAL DISCOMFORT 2 0.0000
459 RENAL IMPAIRMENT 1 0.0000
460 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
461 ADVERSE DRUG REACTION 1 0.0000
462 SWELLING 1 0.0000
463 ANXIETY 3 0.0000
464 CONTUSION 1 0.0000
465 HEART RATE INCREASED 1 0.0000
466 HYPOTENSION 2 0.0000
467 SOMNOLENCE 2 0.0000
468 FLUSHING 1 0.0000
469 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
470 SINUSITIS 1 0.0000
471 OVERDOSE 2 0.0000
472 DRUG INEFFECTIVE 12 0.0000
473 FALL 3 0.0000
474 ASTHMA 1 0.0000
475 SEIZURE 1 0.0000
476 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
477 JOINT SWELLING 1 0.0000
478 VISUAL IMPAIRMENT 1 0.0000
479 DIZZINESS 4 0.0000
480 LOSS OF CONSCIOUSNESS 1 0.0000
481 HYPERHIDROSIS 1 0.0000
482 RENAL FAILURE 1 0.0000
483 PRODUCT QUALITY ISSUE 1 0.0000
484 VISION BLURRED 1 0.0000
485 TOXICITY TO VARIOUS AGENTS 1 0.0000
486 MYOCARDIAL INFARCTION 1 0.0000
487 BLOOD GLUCOSE INCREASED 1 0.0000
488 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000